Sepsis-related deaths globally jumped from about 14 million in 2019 to over 21 million in 2021, driven largely by the COVID-19 pandemic but also by deeper, slower-moving forces that were pushing numbers upward long before the pandemic hit. The rise reflects a collision of demographic shifts, expanding chronic disease, more aggressive medical treatments, growing antimicrobial resistance, and changes in how sepsis gets counted. Untangling which of these matters most reveals that the sepsis problem is not one crisis but several running in parallel.
What the Global Numbers Actually Show
The most comprehensive look at sepsis trends comes from the Global Burden of Disease Study, which tracked cases and deaths across 204 countries from 1990 through 2021. Total sepsis cases worldwide dipped slightly over the three decades before the pandemic, falling about 5.5 percent from roughly 136 million in 1990 to 128 million in 2019. Then COVID-19 arrived and cases surged 30 percent in two years, reaching an estimated 166 million in 2021.1The Lancet Global Health. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis Deaths followed a similar pattern: a slow decline from about 16.5 million in 1990 to 14.1 million in 2019, then a spike to 21.4 million in 2021, representing nearly a third of all global deaths that year. Of those 21.4 million deaths, roughly 7.9 million were directly tied to COVID-19 as the underlying cause.2The Lancet. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
But strip COVID out of the picture and the trend for adults was already going the wrong direction. Among people 15 and older, sepsis incidence climbed 230 percent from 1990 to 2021, and mortality rose over 26 percent. The oldest adults bore the heaviest burden: those 70 and older accounted for roughly 9.3 million sepsis-related deaths in 2021 alone.1The Lancet Global Health. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis The pandemic accelerated an existing trajectory rather than creating one from scratch.
How Much of the Rise Is Real
Before attributing every upward tick to genuinely worsening biology, it helps to acknowledge that the way hospitals code sepsis has changed dramatically. Research examining U.S. hospital claims data found that coding for organ dysfunction, a key marker used to identify sepsis cases, has become increasingly sensitive over time. The clinical threshold for flagging certain organ problems dropped, meaning cases that would have gone undocumented in earlier years started getting counted. This shift alone accounts for much of the apparent rise in severe sepsis incidence that shows up in administrative databases.3PubMed Central. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study
On top of coding changes, the clinical definition itself was overhauled. In 2016, an international task force replaced the older criteria with what is now called Sepsis-3, which dropped the term “severe sepsis” entirely and redefined septic shock more strictly. When researchers applied the new Sepsis-3 shock definition to patients who had been classified as having septic shock under the old rules, only about 43 percent still qualified. The patients who met the newer criteria were genuinely sicker, with higher organ-failure scores and roughly double the mortality rate of those who fell out of the definition.4PubMed Central. The Impact of the SEPSIS-3 Septic Shock Definition on Previously Defined Septic Shock Patients The redefinition was intended to make epidemiological studies more consistent and help clinicians recognize sepsis earlier.5PubMed Central. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) But any change in who counts as a “sepsis case” inevitably reshapes the trend lines, making it hard to compare numbers across eras.
The honest read is that coding artifacts inflate the apparent increase, but real biological and demographic forces are also at work. Neither explanation alone tells the full story.
An Aging World With Aging Immune Systems
The global population is getting older, and older people develop sepsis at strikingly higher rates. Admissions to intensive care units for severe sepsis and septic shock have been climbing in the elderly for years.6PubMed Central. Severe sepsis and septic shock in the elderly: An overview This is not simply because older people get more infections. Their immune systems deteriorate through a process called immunosenescence, where immune cells and organs gradually lose function. That decline leaves older adults less able to mount an effective early response to infection and more prone to the kind of runaway immune dysfunction that defines sepsis.7PubMed Central. Immunosenescence in Sepsis: Molecular Mechanisms and Potential Therapeutic Targets
The scale of this demographic shift matters enormously. The number of people aged 65 and older worldwide has roughly doubled since 2000, and projections suggest it will double again by mid-century. Every additional year of life expectancy gains for a population means more people living with weakened immune defenses and more opportunities for sepsis to develop. The fact that people over 70 accounted for the single largest share of sepsis deaths in 2021 reflects this demographic reality directly.8PubMed Central. Sepsis in Aging Populations: A Review of Risk Factors, Diagnosis, and Management
Chronic Disease as Kindling
People are living longer, but they are also living with more chronic conditions, and each one adds fuel. A large systematic review and meta-analysis found that cancer carried the strongest association with sepsis risk among chronic diseases examined, roughly doubling the odds. Chronic lung disease, kidney disease, and diabetes all showed significant associations as well.9PubMed Central. Risk factors for sepsis: a systematic review and meta-analysis Separate research confirmed those findings and added an important detail: the risk of developing sepsis climbed in a dose-response fashion with the number of chronic conditions a person had. Someone juggling three or four chronic problems faces a meaningfully higher risk than someone with one.10PubMed Central. Chronic Medical Conditions and Risk of Sepsis
The global prevalence of diabetes, chronic kidney disease, and obesity has surged over the past few decades, particularly in middle-income countries undergoing rapid dietary and lifestyle transitions. More people living with these conditions means a larger pool of individuals vulnerable to sepsis at any given time. This is one reason sepsis-related deaths from non-infectious underlying causes, such as stroke, chronic obstructive pulmonary disease, and cirrhosis, actually increased from about 4.7 million in 1990 to 5.8 million in 2021 even as infectious causes were trending downward before COVID.1The Lancet Global Health. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis
Modern Medicine’s Double Edge
Some of the same medical advances keeping people alive longer also create new opportunities for sepsis. Cancer patients receiving chemotherapy, organ-transplant recipients on immunosuppressive drugs, and people undergoing complex surgeries all face heightened infection risk. In cancer patients specifically, cytotoxic drugs, corticosteroids, and immunotherapy suppress the immune system, while treatments often damage protective mucosal barriers and require chronic indwelling catheters that give bacteria a direct route into the bloodstream.11PubMed Central. Septic shock in the immunocompromised cancer patient: a narrative review
Invasive devices of all kinds raise sepsis risk. In a study of hospitalized children, endotracheal tubes carried the greatest daily risk of healthcare-associated infection, and the combination of a central venous catheter and a urinary catheter more than doubled the daily risk.12PubMed Central. Presence of Invasive Devices and Risks of Healthcare-Associated Infections and Sepsis Even common peripheral IV catheters, which are among the most frequently used medical devices worldwide, carry a small but measurable risk of bloodstream infection.13International Journal of Nursing Studies. Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis Multiply that small per-catheter risk by hundreds of millions of insertions annually and the population-level contribution becomes meaningful.
Postoperative infection, meanwhile, showed the most dramatic association with sepsis of any risk factor studied, with odds ratios dwarfing those of chronic diseases.9PubMed Central. Risk factors for sepsis: a systematic review and meta-analysis As surgical volumes worldwide have expanded, particularly elective procedures in aging populations, this pathway to sepsis has grown proportionally.
Antimicrobial Resistance Makes Sepsis Harder to Treat
Drug-resistant bacteria do not just make infections harder to cure. They make sepsis more dangerous because the first round of antibiotics is more likely to miss. When researchers examined patients with culture-proven sepsis, those harboring resistant pathogens like MRSA or carbapenem-resistant organisms were far more likely to receive inadequate initial antibiotic therapy, roughly 40 percent of the time compared with about 11 percent in patients with susceptible bacteria.14JAMA Network Open. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use A separate study focused on gram-negative severe sepsis found that receiving the wrong initial antibiotic roughly quadrupled the odds of dying in the hospital, and that multidrug resistance was strongly linked to receiving inappropriate therapy.15PubMed Central. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
The broader picture is a feedback loop. Antibiotic overuse drives resistance, resistance leads to treatment failures, and treatment failures enable infections to escalate into full-blown sepsis and septic shock. Aging, prior antibiotic exposure, and underlying chronic disease all contribute to recurrent sepsis episodes, which further increase the chance of encountering resistant organisms.16PubMed Central. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge As resistance rates climb worldwide, the window for effective empiric treatment narrows, and sepsis outcomes suffer.
Where Sepsis-Causing Infections Start
Understanding which body sites give rise to sepsis helps explain why certain trends in healthcare and demographics feed the problem. In a large U.S. study of hospitalized sepsis patients, genitourinary tract infections and lower respiratory tract infections were virtually tied as the two most common sources, each accounting for roughly 37 percent of cases, with systemic fungal infections a distant third at about 9 percent.17PLOS ONE. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study When researchers looked specifically at sepsis-related deaths over 15 years, pulmonary infections were the leading site, accounting for about 22 percent of deaths, followed by genitourinary and abdominal sources.18PubMed Central. Sepsis-Related Mortality Rates and Trends Based on Site of Infection
The dominance of urinary and respiratory sources has practical implications. Catheter-associated urinary tract infections are among the most common hospital-acquired infections and are directly tied to the invasive-device risk discussed earlier. Respiratory infections, meanwhile, connect to both viral pandemics and the growing elderly population with chronic lung disease. Secondary bacterial infections during viral pneumonia are a well-recognized pathway to sepsis. In studies of patients hospitalized with viral pneumonia, the mortality rate attributable to secondary bacterial infections was roughly 11 percent overall and about 15 percent in COVID-19 patients specifically.19Frontiers in Medicine. Secondary Bacterial Infections in Patients With Viral Pneumonia
Socioeconomic and Racial Disparities
Sepsis does not hit everyone equally, and the groups most vulnerable are growing in some of the populations least equipped to handle it. Communities with lower household incomes show significantly higher rates of sepsis-attributable death compared with wealthier areas.20PubMed Central. The Effect of Community Socioeconomic Status on Sepsis-attributable Mortality Black Americans experience higher sepsis incidence than white Americans, and a retrospective cohort study found that Black patients with septic shock had roughly 1.6 times the odds of dying within 90 days compared with white patients, even after accounting for severity of illness and comorbidities.21The Lancet Regional Health – Americas. Racial disparities in septic shock mortality: a retrospective cohort study
Broader reviews paint a consistent picture: people with less education, lower income, or no insurance develop sepsis earlier in life and tend to have worse-controlled chronic conditions going in. Mortality and hospital readmission rates are higher for those in low-income or medically underserved areas, those living far from healthcare facilities, and those without insurance. Interestingly, while Black race was consistently associated with higher sepsis incidence, its association with mortality was less consistent once socioeconomic factors were accounted for, suggesting that access and poverty are doing much of the work.22The Journal of Applied Laboratory Medicine. Impact of Socioeconomic Status and Race on Sepsis Epidemiology and Outcomes As income inequality widens in many countries, these disparities become a larger driver of the overall sepsis burden.
The Burden After Survival
Rising sepsis numbers are not just about initial episodes. Survivors face a high risk of coming back to the hospital, often with sepsis again. A meta-analysis of readmission data found that about 5 percent of adult sepsis survivors were readmitted with a new sepsis diagnosis within 30 days, roughly 8 percent within 90 days, and about 16 percent within a year.23Journal of Critical Care. Hospital readmission after surviving sepsis: A systematic review of readmission reasons and meta-analysis of readmission rates These are not random new infections. When researchers tracked which infections brought sepsis survivors back, about 70 percent of the time the infection was at the same body site as the original episode, and half the time it involved the same pathogen.24PubMed. Hospital readmission after surviving sepsis: An analysis of infection recurrence, risk factors and long-term survival
The patients most likely to be readmitted were those with cancer, those on immunosuppressive drugs, and those with higher organ-failure severity during their initial stay. Readmitted patients also had higher long-term mortality than those who stayed out of the hospital.24PubMed. Hospital readmission after surviving sepsis: An analysis of infection recurrence, risk factors and long-term survival This creates a compounding effect: as more people survive an initial sepsis episode thanks to improved acute care, a larger population of sepsis survivors exists, many of whom cycle back through the system. Some U.S. data suggests the 30-day readmission rate has declined modestly over time, from about 9 percent to 8 percent, but even a small percentage of a growing survivor pool translates into substantial hospital volumes.25PubMed Central. Temporal Trends in Incidence, Sepsis-Related Mortality, and Hospital-Based Acute Care after Sepsis
Sepsis in Children and Mothers
While the sharpest increases in sepsis affect older adults, the picture for children and pregnant or postpartum women is more nuanced. Global neonatal sepsis incidence and death rates both declined by roughly 20 percent between 1990 and 2021, with the steepest drops in low-income regions where baseline rates were highest. However, forecasting models suggest neonatal sepsis incidence may begin rising again in low and low-middle income regions through 2050, potentially reversing decades of progress.26PubMed Central. Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990–2021 and predictions to 2050
Pediatric sepsis remains a leading killer of children globally, with mortality ranging from about 5 percent in wealthy nations to 35 percent in developing countries. Much of this gap comes down to delayed diagnosis, late treatment initiation, and limited adherence to treatment guidelines in resource-poor settings.27PubMed Central. Epidemiology of Pediatric Septic Shock For maternal sepsis, incidence and death rates have generally trended downward since 1990, with the steepest decline in death rates. Still, an estimated 19 million maternal sepsis and infection episodes occurred globally in 2021, with the highest rates in women aged 20 to 24.28PubMed Central. Maternal sepsis and other maternal infections: Global Burden from 1990 to 2021 The progress in these groups shows that sepsis can be pushed back with targeted intervention, but it also highlights how fragile those gains are.
Climate, Environment, and Emerging Pressures
A less obvious contributor to future sepsis trends is climate change. Research modeling the relationship between weather and pediatric sepsis in Bangladesh found a nonlinear connection between temperature and sepsis incidence. Cases were lowest at about 27°C and rose sharply above that threshold. Higher rainfall was also associated with increased sepsis rates. A similar pattern held for mortality, with the lowest death rates at around 28°C.29PubMed Central. Modelling climate impacts on paediatric sepsis incidence and severity in Bangladesh The mechanisms likely include heat-driven bacterial growth in water and food, changes in insect-borne disease patterns, and increased vulnerability from dehydration and heat stress.
This line of research is still young, and most evidence comes from tropical and subtropical regions where the effects are most pronounced. But as heat extremes become more frequent across a wider geographic range, climate may become a meaningful amplifier of sepsis in regions that historically had lower baseline rates. Combined with the migration of populations into urban areas with strained sanitation infrastructure, environmental pressures represent a slow-building contributor that most people do not associate with sepsis at all.
Early Detection and Treatment Gaps
One reason sepsis mortality remains stubbornly high despite decades of clinical attention is that the window for effective treatment is narrow and many patients miss it. Federal and state initiatives in the U.S. have pushed hospitals to adopt protocols for early sepsis identification, and most now report having some screening tools in place.30MMWR Morbidity and Mortality Weekly Report. Sepsis Program Activities in Acute Care Hospitals — National Healthcare Safety Network, United States, 2022 But having a protocol and executing it are different things. In lower-resource settings around the world, the combination of delayed diagnosis, late antibiotic initiation, and limited ICU capacity remains the primary reason sepsis kills at such high rates.
There is evidence that pushing treatment even earlier could make a difference. A study comparing sepsis patients who received antibiotics from paramedics before reaching the hospital with historical controls found that the prehospital treatment group spent roughly half as many days in the ICU and needed significantly fewer blood transfusions.31PubMed Central. Prehospital Antibiotics Improve Morbidity and Mortality of Emergency Medical Service Patients with Sepsis The challenge is that sepsis in its early stages can look like many other things: a bad flu, a urinary tract infection, general fatigue in an elderly person. By the time the classic signs of organ failure emerge, the disease is already advanced. Closing that recognition gap, in emergency rooms, ambulances, and especially in community settings, remains one of the biggest levers for reducing the toll.
The Gut Connection
An area of growing research interest is the role of the gut in sepsis. Critically ill patients often develop intestinal barrier dysfunction, where the lining of the gut becomes permeable enough to allow bacteria to cross into the bloodstream, a process called bacterial translocation. This can trigger or worsen sepsis even when the original infection started somewhere else entirely.32PubMed Central. The role of bacterial translocation in sepsis: a new target for therapy Prolonged antibiotic use, which is common in ICU patients, disrupts the normal gut microbiome and may accelerate this process. The gut-sepsis connection helps explain why some patients deteriorate rapidly even after the initial infection seems controlled, and it has opened up research into whether protecting or restoring gut barrier function could reduce sepsis severity. Therapeutic approaches like targeted probiotics and selective gut decontamination are under investigation, though none has become standard care yet.